Answer
Mar 06, 2026 - 11:24 AM
The medication has been approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) as an orphan drug. Orphan drug designation indicates the medication is intended for rare diseases, ensuring access and specialized support for patients.
